Are there specific patient populations where weight-based dosing of pembrolizumab is preferred over fixed dosing?
Year: 2026
Type: article
Abstract: No direct evidence was identified for specific patient populations where weight-based dosing of pembrolizumab is preferred over fixed dosing, although economic factors may favor weight-based dosing in certain cases.
Author: Tripdatabase
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225759788
FWCI:
Cites:
Cited by:
Related to:
